A growing body of evidence from both postmortem and animal studies demonstrates that BDNF and its receptor, tropomyosin-related kinase B (TrkB), are involved in the pathophysiology and treatment of depression [27,28,29,30]. Here, NTRK2 is linked to depressive disorder.